Rapid Drug Desensitization Protocols

Type: procedure

Status: FDA Approved

Developer: Various academic institutions (e.g., Brigham and Women's Hospital)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026